Shenzhen Idepass Technology Co., Ltd – Trademark Portfolio
Entity Type: 99
Shenzhen Idepass Technology Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IDEPASS and AIMEIFACE. The owner is based in Shenzhen,Guangdong,.
553&555,Dongming Bldg.,Minkang Rd.,Zhang
keng Community,Minzhi St.,Longhua Dist.,
Shenzhen,Guangdong, 518110 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Idepass Technology Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shenzhen Idepass Technology Co., Ltd have?
Shenzhen Idepass Technology Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Shenzhen Idepass Technology Co., Ltd file in?
Shenzhen Idepass Technology Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Shenzhen Idepass Technology Co., Ltd's most well-known trademarks?
Shenzhen Idepass Technology Co., Ltd's registered trademark portfolio includes well-known marks such as IDEPASS and AIMEIFACE. These are among 2 currently registered trademarks in the portfolio.
What is Shenzhen Idepass Technology Co., Ltd's trademark registration success rate?
Shenzhen Idepass Technology Co., Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.